ARK Investment Management ENLIVEX THERAPEUTICS LTD ownership

ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 3 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

ARK Investment Management ownership history of ENLIVEX THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$1,658
-31.7%
331,001
-23.8%
0.01%0.0%
Q1 2022$2,428
+11.2%
434,343
+24.3%
0.01%
+42.9%
Q4 2021$2,183
-51.7%
349,308
-23.7%
0.01%
-36.4%
Q3 2021$4,523
-1.3%
457,797
-11.1%
0.01%
+22.2%
Q2 2021$4,582
-13.3%
514,807
+8.1%
0.01%
-10.0%
Q1 2021$5,283
+1535.6%
476,414
+1136.3%
0.01%
+25.0%
Q4 2019$32338,5360.01%